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endemic foot and mouth disease: 
pastoral in-herd disease dynamics 
in sub-Saharan Africa
i. McLachlan  1,2*, G. Marion 2, I. J. McKendrick  2, T. porphyre  1, I. G. Handel1,3 & 
B. M. dec. Bronsvoort  1
Foot and mouth disease (FMD) burden disproportionally affects Africa where it is considered endemic. 
Smallholder livestock keepers experience significant losses due to disease, but the dynamics and 
mechanisms underlying persistence at the herd-level and beyond remain poorly understood. We 
address this knowledge gap using stochastic, compartmental modelling to explore FMD virus (FMDV) 
persistence, outbreak dynamics and disease burden in individual cattle herds within an endemic setting. 
our analysis suggests repeated introduction of virus from outside the herd is required for long-term 
viral persistence, irrespective of carrier presence. Risk of new disease exposures resulting in significant 
secondary outbreaks is reduced by the presence of immune individuals giving rise to a period of 
reduced risk, the predicted duration of which suggests that multiple strains of FMDV are responsible for 
observed yearly herd-level outbreaks. our analysis suggests management of population turnover could 
potentially reduce disease burden and deliberate infection of cattle, practiced by local livestock keepers 
in parts of Africa, has little effect on the duration of the reduced risk period but increases disease 
burden. This work suggests that FMD control should be implemented beyond individual herds but, in 
the interim, herd management may be used to reduced FMD impact to livestock keepers.
Many livestock keepers in sub-Saharan Africa (SSA) experience annual outbreaks of foot and mouth disease 
(FMD)1. Losses2–4, mainly as a result of reduced milk production and loss of draft power5, are significant and 
pastoral and smallholder farmers are vulnerable due to their reliance on livestock for their livelihoods and food 
security6. Although formal economic losses are not typically the primary concern of smallholders5 and pasto-
ral livestock keepers in low and middle income (LMICs) settings, reduced income from livestock also limits 
spending capability on human health7, education and food. Livestock also remain important for social status and 
cultural identity in large parts of SSA8. Therefore further efforts need to be made to understand and control FMD 
in endemic settings.
South America has made good progress in reducing FMD incidence through vaccination and outbreak 
response surveillance9. However, it is not clear that such successes will be easy to replicate in remaining endemic 
regions. Vaccination coverage in South America, where huge control efforts have been made, is estimated to 
be 146.1%10, reflecting vaccination of animals more than once per year on average. In contrast it is estimated 
that 5.5% of the African cattle population vaccinated10. Resources and spending on FMD control varies widely 
between endemic countries11. The lack of resources available for animal disease control in SSA means large-scale 
government control programs are likely to be limited and therefore the burden of control falls on individual 
livestock keepers and their communities12. Control measures implemented vary between smallholders. Although 
a study of smallholders in Kenya found vaccination and movement restriction to be the most common control 
measures, nearly a third of those surveyed did nothing to prevent disease13. Whilst just under half of respondents 
vaccinated, less than a quarter had vaccinated within the last 6 months – the recommended vaccination fre-
quency for FMD. Willingness to pay for vaccination is likely to be greater when the risk of disease is immediate 
(i.e. emergency vaccination) but poor access to veterinary services and a lack of resources to purchase drugs 
inhibit the implementation of vaccination based control among smallholders/pastoralists in SSA14. Even limited 
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improvements to current control in SSA are predicted to have a socioeconomic benefit for livestock keepers5. 
Therefore, in the near to medium term, the best strategy for control is likely to involve targeting individual live-
stock keepers, which requires improved understanding of within-herd dynamics. It is important that those under-
taking control perceive it to be successful and cost effective. This is particularly true in the context of low-risk, 
low-reward farming systems where future planning for disease control is limited and there are often significant 
barriers to investing in increased productivity11. In addition, long term participation and compliance are impor-
tant for sustained disease control. Therefore, before encouraging livestock keepers to invest in control it is impor-
tant to understand how they will benefit as individuals.
Identification of effective control measures for FMD in pastoral West and Central Africa requires an under-
standing of endemic FMD that we currently do not have11. There are seven distinct serotypes of FMD virus 
(FMDV) (type A, O, C, Asia1 and Southern African Territories (SATs) 1, 2 and 3)), which have different geo-
graphical distributions – all but Asia1 have been found in SSA15. There is little evidence for cross protection 
between the different serotypes, therefore, they can be explored largely independently. However, different sero-
types of FMD virus are clinically indistinguishable and multiple serotypes co-circulate in endemic regions in SSA. 
This complicates efforts to distinguish the dynamics of the individual serotypes from the observed disease in the 
field. Understanding of FMD in endemic regions is largely informed by cross-sectional studies. While this is ben-
eficial for providing an overview of FMD it can be difficult to understand ongoing disease dynamics, particularly 
at the herd-level.
The potential role of carriers in FMD dynamics and persistence is an example of an open question where the 
scientific debate has yet to arrive at a consensus. A carrier is, by definition, an individual from which virus can be 
recovered more than 28 days after infection16. It is unclear whether carriers contribute to transmission of FMD. 
There are anecdotal reports of transmission17 but until recently this had not been shown in experimental stud-
ies18. Arzt et al. have shown transmission of FMD from carriers to naïve cattle through transfer of oropharyngeal 
fluids19. Although not reflective of transmission in field settings, this finding once again brings into question the 
role of carriers in FMD dynamics. Although studies have explored the epidemiology of carriers due to the lack of 
evidence for transmission it is assumed that the role of carriers in disease dynamics within the herd is negligible. 
It is important to understand if this is true and whether the presence of carriers would alter advice given to herd-
ers, particularly as vaccination does not protect against the development of carrier status20.
Modelling provides a valuable tool for bringing together existing knowledge within a coherent and logical 
framework, and highlights areas where more, better quality data are required to improve our understanding of 
the epidemiology of a disease. However, most FMD modelling focuses on FMD-free settings where availability of 
good quality data has enabled detailed study on the mechanisms underlying the spread of FMDV and improved 
its control in epidemic settings21–23. Furthermore, varying levels of immunity and greater movement and inter-
action between herds are generally not relevant in FMD-free settings but need to be considered in endemic 
settings. The few endemic FMD24,25 models used in attempts to understand persistence within endemic coun-
tries and to estimate certain parameters26 have not explored the within-herd dynamics of FMD in cattle in an 
endemic setting. Disease dynamics vary across different scales so in order to understand within herd dynamics 
disease transmission needs to be modelled at such a scale. Here we develop a stochastic compartmental model 
for within-herd FMD dynamics and parameterise it using the best available information from the literature on 
FMD in smallholder pastoral cattle herds in endemic settings. We use this framework to enhance understanding 
of endemic FMD by addressing the following questions: (1) How does the role of carriers and infection memory 
affect the long-term persistence of FMDV in cattle herds in a setting typical of pastoralists in SSA?; and (2) How 
does herd management affect disease recurrence and burden?
Results
Persistence, carriers and infection memory. We developed a stochastic, compartmental model to 
explore disease persistence and dynamics. The model structure is of the form susceptible-exposed-infectious-re-
covered-carrier (SEIRC) (Fig. 1). By varying the proportion of infectious individuals that become carriers before 
recovering (θ) we explored scenarios with and without carriers. We modelled a herd of 7027 individuals. We 
assumed no disease associated death in our model as FMD related mortality is very low in adult cattle28–30 and 
individuals leaving the population were replaced with susceptible individuals. A basic reproductive number 
(R0) of 424,31–35, latent period (Tlatent) of 4.6 days36,37 and the infectious period (Tinfectious) 1.7 days36 were used. To 
Figure 1. Within-herd FMD model. β - transmission parameter, λ - per-capita rate of onset of infectiousness, 
σI - per-capita rate of recovery from the infectious period, θ - proportion of infectious individuals that become 
carriers, σC - per-capita rate of recovery from the carrier state and μ - per-capita rate of removal from the herd.
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maintain a consistent R0, reflective of observed outbreaks, the transmission parameter (β) was adjusted for each 
of different scenarios (see Methods). The model was initialised with a single infectious individual and evaluated 
through 50 years the level of prevalence in the herd while accounting for herd management practices. Once sim-
ulations ended, outbreaks were classified as ‘small’ or ‘large’ based on the total number of incident animals that 
were infected within the herd during the study period. Here, large outbreaks are defined as ones in which more 
than 10% of the population are infected (all other outbreaks are classified as small). The results presented repre-
sent 10000 simulations of the model.
Using this model, we explored the herd-level persistence and dynamics with and without a carrier state 
(θ = 0.538,39 and θ = 0). To explore whether disease can persist within a single herd we simulated outbreaks and 
recorded size and duration. Outbreak duration was measured as the time during which exposed or infectious 
individuals were present in the herd. Estimates of carrier characteristics from empirical studies vary and it is 
unclear if such individuals can transmit virus. To investigate whether a carrier state may alter persistence and 
disease dynamics we have used a range of relative (i.e. relative to that from the infectious state) transmission rates 
(ω). Viral persistence was measured as the time during which exposed, infectious or carrier individuals were pres-
ent in the herd and the number of infectious individuals during this time was recorded. The reduced risk period 
(TReducedRisk) is defined as the time interval, following the initial outbreak, for which the effective reproductive 
number (Rt) is less than 1. We measured the proportion of outbreak, initiated by a single carrier, that were large. 
Through model simulation we also investigated the relationship between the inter-outbreak period and the size 
of the subsequent outbreak resulting from disease incursion into the herd.
In the scenario in which no carrier state is involved in the dynamics of FMDV in a typical cattle herd disease 
cannot persist – no simulations showed FMDV remaining in the herd within the 50 years simulated. Indeed, the 
mean duration of all simulated outbreaks was 0.083 years (95% CI: 0.082 to 0.084 years) and the maximum less 
than 0.25 years (Fig. 2a). Between 1 and 7 individuals were infected in 25% of the simulations whereas 75% of 
simulations permitted outbreaks of 61 to 72 infected individuals (Fig. 2b), for a herd size of 70 animals. Although 
the herd size was fixed to 70 individual cattle, 4% of simulations showed a number of incident cases that were 
greater than 70, highlighting that replacement individuals will ultimately be infected if introduced into a herd in 
which FMD is actively circulating.
In contrast, when adding a carrier state, the mean viral persistence within the herd is markedly prolonged, 
with a mean persistence increasing from less than 0.25 years to more than 2 years. In addition, increasing the 
value of ω from 0 to 0.025 yields only minor changes (Fig. 3a). However, mean disease persistence (outbreak 
duration) remains similar to the persistence seen in models without carriers, although this again increases slightly 
as ω increases (Fig. S1a, Supplementary Material). The mean total number of individuals becoming infectious 
whilst virus persists does increase as ω increases, but the difference is less than 10 for the range of ω explored 
(Fig. 3b). Mean TReducedRisk decreases only slightly as ω increases (Fig. 3c). When ω is high large outbreaks are, on 
average, smaller (Fig. S1b, Supplementary Material) and therefore less time is required for the herd to regain a 
level of susceptibility that would support further outbreaks. The risk of a single carrier initiating a large outbreak 
is shown in Fig. 3d. Increased ω increases the probability that a single carrier will initiate a large outbreak, how-
ever, the probability of a large outbreak is lower than if the initial individual were infectious. Overall these results 
suggest that, other than the duration of viral persistence, measures of herd-level disease dynamics are similar 
whether carriers are included in the model or not. Therefore, results presented in the remainder of the paper use 
the simpler model without carriers (however, for completeness additional results with carriers are shown in the 
Supplementary Material; Figs S1–S4).
Herds have memory of pervious outbreaks as currently immune individuals exposed in previous outbreaks 
cannot be infected. Herd memory does affect future outbreaks (Fig. 4). Following large outbreaks there is a period 
where the herd is at reduced risk of further outbreaks (Fig. 4a). The mean TReducedRisk is longer when susceptibility 
prior to the initial outbreak is high (1.61 years when 50% of the herd is susceptible and 2.68 years when 100% 
of the herd is susceptible). Generally, higher immunity following an outbreak results in longer TReducedRisk, and 
higher susceptibility prior to an outbreak results in higher average immunity (Fig. 4b) following a large outbreak. 
The longer the inter-outbreak interval the higher the probability that subsequent outbreaks will be large (Fig. 4c). 
Given that a large outbreak has occurred, when the inter-outbreak period is 7 years there is a greater than 50% 
probability that the second outbreak will also be large. When the inter-outbreak period is greater than 20 years the 
Figure 2. Disease cannot persist within a single herd. The mean duration of large outbreaks is 0.083 years  
(0.99 months) with 100% of outbreaks lasting less than 0.27 years (3.2 months) (a). The majority of outbreaks 
are large although some small outbreaks are observed (b).
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Figure 3. Impact of Carriers. Carriers increase viral persistence within a herd following an initial disease 
incursion regardless of the relative transmission from carriers (ω) (a). The total number of individuals infected 
whilst virus persists is similar to a herd without carriers (b). The average reduced risk period increases with a 
very small increase in ω but then decreases as ω increases further (c). When carriers are able to transmit FMDV 
there is a (non-zero) probability that a single carrier initiates a large outbreak (d).
Figure 4. Memory of herd immunity following a large outbreak. Following an outbreak there is a period 
where the herd is at reduced risk (TReducedRisk) of further outbreaks (a). Higher immunity (more non susceptible 
individuals) within the herd following a large outbreak (increased by greater susceptibility prior to the outbreak) 
extends TReducedRisk (b). The longer the inter-outbreak period the greater the probability that the subsequent 
outbreak will be large (c) and these large outbreaks will, on average, infect more individuals (d).
5Scientific RepoRtS |         (2019) 9:17349  | https://doi.org/10.1038/s41598-019-53658-5
www.nature.com/scientificreportswww.nature.com/scientificreports/
probability that the second outbreak is large is similar to the probability of a large outbreak in a fully susceptible 
population. As the inter-outbreak interval increases so too does the average size of the second outbreak – the 
average size of large outbreaks increases whilst the average size of small outbreaks remain similar (Fig. 4d). The 
average size of small outbreaks changes very little regardless of the inter-outbreak interval.
implication of herd management on outbreak frequency and burden. We explored two herd man-
agement practices to understand how they affect the TReducedRisk following a large outbreak: changing average 
Tin-herd by varying the population turn-over (μ); and the efficacy of the practice of deliberate infection. The former 
is largely under the control of herders as it reflects the replacement rate of animals within the herd as well as their 
typical lifespan. Deliberate infection purposely exposes animals to infectious material when disease is nearby. It 
is still practiced as a methods of FMD control in some developing countries to reduce uncertainty surrounding 
infection and the duration of disease impact40 and to provide immunity to animals that survive infection. In our 
modelled scenario when an individual other than the initially infected individual became infectious a propor-
tion of the remaining susceptible population was deliberately infected (i.e. was made to enter the exposed state). 
FMD burden associated is high and the impact is felt not only during the outbreak but afterwards as recovered 
individuals may be less productive. We explored whether average Tin-herd may be used to minimise disease burden 
associated with FMD (without preferentially removing animals of particular disease states).
Burden was measured separately for infectious and recovered individuals as the total number of days per year 
spent in each of the disease states. Overall burden combines these two measures, weighting a day in the recov-
ered class as a fraction (δ) of a day in the infectious class (i.e. we have chosen to weight infectious burden more 
highly than recovered burden). A study of a dairy farm in Kenya reported reduction in daily milk yield during an 
outbreak, following the outbreak milk yield recovered but not to pre-outbreak levels41. The robustness of optimal 
strategies to reduce burden was assessed using a range of such weightings.
Results show that herd management practices can alter the TReducedRisk following a large outbreak (Fig. 5). 
Tin-herd has a strong impact on the TReducedRisk (Fig. 5a). Shorter Tin-herd results in a shorter mean TReducedRisk. Our 
model assumes that individuals leaving the herd are replaced with susceptible individuals. When more of the 
replacement individuals are in the recovered class rather than susceptible the mean TReducedRisk is longer (Fig. S6, 
Supplementary Material). When the population is partially susceptible and a higher proportion of the susceptible 
population is deliberately infected there is a slight increase in the average TReducedRisk (Fig. 5b). This is because 
deliberate infection increases the average outbreak size.
In fully susceptible populations, 100% effective deliberate infection increases TReducedRisk by 0.24 years. 
Increasing the in-herd residency from 10 to 11 years would have a similar impact (increasing TReducedRisk by 0.27 
years). When the herd is 75% susceptible prior to the outbreak increasing in-herd residency from 10 to 12 years 
increases TReducedRisk equivalent to deliberate infection. In herds where 50% of the herd is susceptible prior to the 
outbreak increasing in-herd residency from 10 to 18 years is required to produce the same increase in TReducedRisk 
as deliberate infection.
Mean infectious disease burden decreases as average Tin-herd increases (Fig. 6a) whilst the mean recovered 
disease burden increases (Fig. 6b). Longer Tin-herd is the optimal strategy when recovered burden does not con-
tribute to overall burden (Fig. 6c). A higher δ favours shorter Tin-herd. We have measured the variation between 
the minimum and maximum estimates for burden as a percentage of minimum disease burden (Fig. 6d). Across 
the parameter space, the percentage difference between the minimum and maximum total burden varies between 
5 and 106% relative to the minimum burden. There is more variation between the minimum and maximum 
estimates for burden when only infectious individuals contribute to the overall burden. Increasing the propor-
tion of the population deliberately infected increases both infectious and recovered disease burden (Fig. S5, 
Supplementary Material).
Figure 5. Impact of herd management on the reduced risk period (TReducedRisk) following a large outbreak. 
Shorter average in-herd residency shortens TReducedRisk (a – the rate of population turn-over (μ) is varied), 
increasing the proportion of individuals deliberately infected results in a longer mean TReducedRisk following an 
outbreak (b – once an outbreak is detected deliberate infection of a proportion of the remaining susceptible 
individuals occurs).
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Discussion
The negative impact of FMD in endemic regions has been well documented5–7,10 but understanding of disease dynamics 
is poor8,11. Countries in FMD endemic SSA are at the very early stages of the Progressive Control Pathway for FMD, 
prior to the implementation of control12. In such countries resources needed to control FMD compete with spending 
on health and education and other agricultural programs supporting staple foods42. Therefore national or regional level 
control programmes are likely to have limited impact in the short to medium term and individuals must continue to 
manage their herds as best they can in the context of FMDV circulation. Our study aims to support such management 
systems. Specifically we address a current gap in the literature by developing a within-herd transmission model based 
on the best available information on FMD in endemic regions, contributing to improved understanding of within herd 
disease dynamics. Our analysis of this model addresses a number of important issues and highlights important gaps 
in FMD knowledge and associated herd management practices in endemic regions. This analysis suggests that FMD 
cannot be sustained in an isolated herd. Hence, repeated introduction of virus from outside the herd is likely responsi-
ble for the frequent outbreaks observed in endemic regions43,44. Our study has also highlighted the limited availability 
of information about smallholder farmers and pastoralists and how they are affected by FMD, in particular a lack of 
longitudinal data. Availability of good quality data will be important in identifying the difference between outbreaks 
observed by smallholders and the true underlying disease dynamics.
Smallholder and pastoralist livestock keepers in endemic regions are caught in a cycle of repeated outbreaks. 
To obtain insight into how this ongoing threat of outbreaks affects disease dynamics within individual herds, we 
considered pairs of outbreaks; a large initial or first outbreak, against a background of varying levels of herd sus-
ceptibility reflecting the range of within-herd in endemic regions45, followed by a second or subsequent outbreak 
caused by disease incursion. We refer to the time between the end of the first outbreak and the subsequent incur-
sion as the inter-outbreak period. Large secondary outbreaks, where more than 10% of individuals are infected, 
are rare when incursions occur soon after the end of the initial outbreak. In contrast, larger secondary outbreaks 
are more likely when the inter-outbreak period is longer or when immunity prior to the initial outbreak is higher. 
However, the herd susceptibility prior to the initial outbreak exerts a strong influence on whether a second out-
break, one year later, is large. When pre-initial outbreak susceptibility is only 50% the probability of a large second 
outbreak one year after the first is only 0.12. Full herd susceptibility prior to the first outbreak reduces this prob-
ability to 0.02. To understand this difference consider that the typical initial outbreak size and levels of immunity 
following it are reduced when herd susceptibility is lower. Therefore the herd will typically recover susceptibility 
to be able to support another outbreak more quickly.
The inter-outbreak period also has a strong effect on the characteristics of a second outbreak. The probability 
that a large outbreak follows the initial large outbreak increases above 50% when the inter-outbreak period is 
greater than 7 years. A small sample of within-herd outbreaks in Cameroon suggest that outbreaks infect around 
Figure 6. Disease burden varies with average in-herd residency. Mean infectious (I) disease burden decreases 
with increasing average in-herd residency (a). Mean recovered (R) disease burden increases with increasing 
average in-herd residency (b). Higher relative contribution of recovered individuals (δ) to overall disease 
burden favours shorter in-herd residency (c). There is greater variation between maximum burden relative to 
minimum burden when δ is low (d).
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37% of the herd, with outbreak size varying between 15 and 71%46. These outbreaks are by our definition large 
and on average leave 63% of the herd susceptible. If typical of the near annual outbreaks observed within pastoral 
herds in endemic regions43,44 this suggests that consecutive outbreaks are caused by different strains of FMDV 
with poor cross-immunity as it is unlikely herds will regain susceptibility to a given strain quickly enough to 
experience yearly outbreaks of this size. This is consistent with the suggestion from Bronsvoort et al. that the 
appearance of persistence could be achieved through different FMDV strains passing through a population47. 
This is supported by the recent observation in eastern Africa of waves of outbreaks each with a single dominant 
serotype7. Clinical signs of FMD are indistinguishable between serotypes but are typically relied upon to measure 
the size and impact of outbreaks in endemic settings. Thus although observationally disease may persist it is likely 
that the dominant strain changes. Limited data across endemic regions26 makes it difficult to confirm this hypoth-
esis, but the model-based analysis presented in this paper supports the idea that observed frequency of outbreaks 
in endemic regions is likely due to co-circulating strains of FMDV. Although challenging to collect, longitudinal 
data would also enable better understanding of the dynamics of FMD and data from different geographical loca-
tions would provide information on regional differences45,48.
Our model-based analysis contributes to the ongoing debate around the role of carriers in FMD dynamics. 
We explore a range of relative transmission rates from carriers (ω), reflecting uncertainty of the contribution of 
carriers to FMD transmission. To enable direct comparison, an equivalent within-outbreak R0 value was used in 
all simulations, both with and without carriers. We show that the existence of a carrier state can increase mean 
viral persistence within an isolated herd from less than one month to more than 2 years but does not result in 
indefinite persistence. Crucially, the inclusion of carriers in our model does not reproduce the frequency and size 
of outbreaks observed in the field43,44. Other characteristics explored, including the effect of herd management 
strategies on the reduced risk period (TReducedRisk) and disease burden, are similar to those in the model without 
carriers. Mean outbreak duration and total infection increase slightly as ω increases but are similar to results with-
out carriers. The mean TReducedRisk remains fairly constant as ω increases; however, carriers do represent an addi-
tional source of disease risk. The probability that a carrier initiates a large outbreak is lower than for an infectious 
individual, but, as expected, increases as ω increases. The potential for carriers to start outbreaks is important in 
FMD-free settings and is a major driver for the use of culling to control outbreaks. Whether carriers are able to 
transmit disease or not, our results suggest that their impact on FMD dynamics in individual pastoralist herds 
is small. However the prolonged infectiousness of herds when carriers are present provides greater opportunity 
for transmission between herds and may have implications for regional disease persistence. This effect is likely to 
become more important as control progresses towards eradication/elimination.
We find that herd management practices have potential to influence outbreak frequency and manage bur-
den. High levels of herd immunity reduce outbreak risk. Pastoralists tend to rely on traditional and/or reactive 
treatments49,50 and as vaccination is not a common practice in FMD endemic pastoralist Africa we assume that 
all immunity is naturally acquired and life-long. Our results that show longer average in-herd residency (Tin-herd) 
increases mean TReducedRisk. In pastoral systems most trade results in animals being removed from the herd while 
replacement animals tend to be bred by the livestock keepers. One study showed 93.3% of new entries into the 
herd resulted from births with the remaining 6.7% from purchases51. FMD mortality is low10 but negatively affects 
herd fertility52 and is likely to slow population turn-over and increase costs. Previous exposure to disease may 
have further implications for herd dynamics (not explored here) if livestock keepers choose to sell less productive, 
previously exposed, individuals. However, this has not been observed in pastoralist communities in the Far North 
Region of Cameroon49 and would more likely occur in more profit-orientated commercial farms. Here we show 
that it may be possible to minimise disease burden without preferentially selling animals of a particular disease 
state. The optimal strategy depends on a number of factors including, which disease state experiences most of 
the negative effects of FMD, the outbreak size, and the pathogenicity of the viral serotypes30,53. Because of these 
sources of uncertainty, and the effect of (unknown) variation in herd immunity prior to disease incursion, further 
work is required before making specific recommendations regarding such management of small herds.
The deliberate infection of livestock may seem counterintuitive, but it is still practised as it reduces uncertainty 
and variability of infection and the overall likely duration for which the herd has clinical disease40. The time 
during which the herd is immobilised due to disease is reduced allowing the search for better grazing or markets 
to resume more quickly (factors not considered in our analysis). Higher levels of success in inducing infection 
increases the mean TReducedRisk due to the occurrence of larger average outbreaks than would be predicted without 
such intervention. This beneficial effect on the mean TReducedRisk is small but is more apparent when the herd has 
reduced susceptibility prior to the outbreak, which may be more likely in endemic regions. Our results suggest 
that deliberate infection, to reduce short-term uncertainty surrounding infection, increases disease burden on 
average. Mean outbreak size increases with greater success in deliberately causing infection, thereby increasing 
burden associated with infectious individuals. Larger average sizes of outbreaks also increase the number of 
individuals who may experience negative effects resulting from FMD after the outbreaks end, increasing disease 
burden in the long term. These results suggest that it would be beneficial for herders to cease this practice however 
further comparison between the short and long-term costs and benefits would need to be conducted to provide 
more definitive advice. In addition to increasing the number of animals who may experience negative effects of 
FMD after an outbreak has ended it has also been suggested that deliberate infection of animals with FMD may 
increase the probability of individuals becoming carriers42. Our findings suggest the implications, at the herd 
level, of carriers resulting from deliberate infection is likely to be minimal.
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conclusions
Our model strongly suggests that disease cannot persist without re-introduction of FMDV within a single herd. 
Even disease transmitting carriers are insufficient for disease persistence. Previous models have also struggled to 
replicate disease persistence24 highlighting the complexity of endemic systems and the need for additional work. 
We show there is a reduced average risk period following outbreaks which is typically longer than the average 
period between outbreaks in FMD endemic regions. Although herd management practices alter the rate at which 
herds regain susceptibility to disease our analysis suggests it is implausible that herds to experience yearly out-
breaks of the same FMDV serotype. Neither the reduced risk period nor the effects of herd management practices 
are significantly affected by the addition of a carrier state. Future work would benefit from a meta-population 
model approach, incorporating transmission between herds and risk of transmission from wildlife to better 
understand between-herd persistence and disease recurrence within herds. Such modelling studies would benefit 
from additional endemic region data on the frequency of outbreaks and the serotypes responsible, to disentangle 
the observed outbreaks from the dynamics of the circulating serotypes. The majority of farming in FMD endemic 
regions operates under a low-risk, low-reward system and as a result particular care needs to be taken when mak-
ing recommendations regarding FMD control strategies. Better informed models would increase confidence in 
recommendations targeted at smallholders in endemic regions.
Methods
Model structure. We develop a stochastic, compartmental model of the form susceptible-exposed-infec-
tious-recovered-carrier (SEIRC) (Fig. 1) in order to investigate within-herd FMD dynamics in endemic regions. 
The model is Markovian; times spent in each state follow an exponential distribution with average residence time 
given by the reciprocal of the rate of transition out of the given state (Table 1). Susceptible (S) individuals become 
infected at a rate determined by frequency-dependent transmission. Upon infection, susceptible individuals enter 
an exposed state36,37 (E) but are not capable of transmitting virus. Following a latent period exposed individuals 
become infectious (I) at a per-capita rate λ. Individuals leave the infectious state at a per-capita rate σI. A propor-
tion (θ) of these individuals become carriers16 (C) and the remaining fraction (1-θ) enter the recovered state (R). 
Individuals leave the carrier state at per-capita rate σC entering the recovered state. Natural immunity has been 
shown to be long-lived in cattle54,55 and therefore we have assumed that those in the recovered state have life-long 
immunity. No disease induced mortality is considered due to the low mortality associated with FMD infection in 
cattle28,29,44. However, all disease states are subject to a per-capita rate of population turnover, μ, which represents 
both natural deaths and other removals from the herd. A constant population was maintained by replacing indi-
viduals leaving the herd with susceptible individuals. The model was coded in C + + using Xcode (version 8.1) 
and implements the Gillespie direct method56.
Model parameterisation to reflect smallholder subsistence livestock keepers in Africa. Our 
model herd has 70 individuals, reflecting an estimate of average herd size of subsistence livestock keepers in 
Cameroon27. In all simulations we have used an R0 of 4, which is within the range of reported R0 in endemic regi
ons24,31,32,34,57. To investigate different scenarios we have varied parameters from baseline values (Table 2). For 












). The average dura-
tion of the latent period (Tlatent) is 4.6 days, and the average duration of the infectious period (Tinfectious) 1.7 days36. 
Background population turnover is assumed to be 1
10
 years−1. This is comparable to 1
11 08.
 years−1 as used by 
Jemberu et al.58. Ducrotoy et al.51 reported that cattle were kept until eight years old (or longer if reproductively 
proficient) therefore we believe that an average in-herd residency of 10 years is an appropriate approximation.
The duration of the carrier state (Tcarrier) is often reported to be 3.5 years38,59,60 but this likely represents the 
upper limit. Several studies have suggested shorter Tcarrier with estimates ranging from 6 to 13 months57,61,62. 
Therefore, we have chosen to assume a relatively short Tcarrier of 6 months (per-capita rate of recovery from the 
carrier state is 1
6
 months−1). Virus likely persists in the majority of individuals for several months after infection63 
however estimates of the proportion affected varies. We have chosen to use a 50% probability of becoming a car-
rier (θ) in our model. This is consistent with values reported by Moonen and Schrijver and Arnold et al.38,39. We 
do not know if carriers can transmit FMD, but if possible, it is highly likely that the transmission rate from carri-
ers will be low compared to that from infectious individuals. One study has estimated the relative transmission 
Event Equation Population Change
Birth/Death* (turnover) μS + μE + μI + μR + μC −1 S/E/I/R/C and +1 S
Infection S I C
N
( )β ω+ −1 S and +1 E
Becoming infectious λE −1 E and +1 I
Entering a carrier state θσII −1 I and +1 C
Recovery from the infectious state (1−θ)σII −1 and +1 R
Recovery from the carrier state σcC −1 C and +1 R
Table 1. Events changing the population in response to disease. *The equations shown refer to the death rate in 
the population. In the model birth occurs at the same time as death to maintain a constant population size. The 
overall event therefore corresponds to turnover in the herd.
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rate from carriers (ω) as = .0 0021
500
 that from infection individuals18. We have therefore chosen to vary ω 
between 0.000 and 0.025 allowing us to explore the impact of carriers on dynamics of FMD and persistence.
Modelled scenarios. We have used two scenarios to answer questions about FMD persistence and 
within-herd dynamics posed in the Introduction. Scenario A explored the dynamics during and after a single out-
break. Outbreaks were initiated with a single infectious individual. The remainder of the population were either 
susceptible or recovered. Simulations were initiated with 50, 75 or 100% of the herd being susceptible. This reflects 
the range of within-herd sero-prevalence in endemic regions45. Scenario A was used to explore: disease persis-
tence within a single herd; the period of reduced risk (TReducedRisk) following a large outbreak and how this can be 
affected by herd management. Scenario B simulated two outbreaks. The first of these outbreaks was initiated in 
the same way as scenario A. The second outbreak occurred a set time after the end of the previous outbreak. The 
second outbreak was initiated by a susceptible individual becoming exposed (S to E) representing exposure from 
sources outwith the herd. Set inter-outbreak periods of between 1 and 30 years were used when exploring how 
memory of a large outbreak affects the future risk of an outbreak in a herd. The short inter-outbreak period of 1.2 
years was used to explore disease burden as an approximate reflection of the frequency of outbreaks observed in 
the field7,44. We modelled these scenarios with and without a carrier state collecting information from the simu-
lations to investigate how carriers alter dynamics at the herd-level.
Model statistics. The following statistics were calculated from simulation results: outbreak size and dura-
tion; disease and viral persistence; TReducedRisk; and disease burden. Outbreak size counts the number of individuals 
that become infectious during the outbreak. Outbreak duration (disease persistence) was defined as the time 
during which at least one exposed or infectious individual was present in the population and viral persistence 
as the time during which at least one exposed, infectious or carrier individual was present in the population. 
TReducedRisk was measured as the period of time from the end of an outbreak until the effective reproductive num-
ber Rt was greater than 1. Disease burden was calculated for infectious and recovered individuals as total number 
of individual-days spent within each state respectively. Infectious disease burden aims to account for the cost of 
FMD during an outbreak whilst the recovered disease burden is almost entirely made up of the effects of FMD felt 
after an outbreak has ended. Overall burden combined infectious and recovered burden weighting a recovered 
day as a proportion of an infectious day. Reported mean values are calculated from 10000 simulations.
The distribution of outbreak size is affected by the proportion of susceptible individuals in the population 
prior to an outbreak (Fig. 7a). In a fully susceptible population outbreak size follows a bimodal distribution. 
Outbreaks simulated in a herd with 70 individuals infect between 1 and 7 individuals or 61 and 72 individuals. 
From this we have defined a large outbreak as any in which more than 10% of individuals become infectious. As 
herd susceptibility falls the size of large outbreaks gets smaller and there are fewer large outbreaks. Average out-
break size varies with the immunity in the herd prior to the outbreak (Fig. 7b). The basic reproduction number 
(R0), calculated for each model using the next generation matrix approach64 (R SEIR0 ( )( )I=
βλ
λ μ σ μ+ +
 and 
= + ωθσ
σ μ+( )R R 1SEIRC SEIR0 0 ( )IC ) refers to the average number of new cases resulting from a typically infectious 














) is a meas-
ure of the average number of new cases resulting from a typically infectious individual in a partially susceptible 
population. Herds are considered to be at reduced risk of further outbreaks whilst Rt is less than 1. Figure 7b 
Parameter Value Units Range of values References
R0 4
2–12 (modelling, Far North Cameroon)24
Infinity (final size calculation)31
2.52 (final size calculation, vaccinated calf population)32
14 (unpublished observation)33
2.4–3.8 (estimated before an outbreak was officially 
reported (prior to mass vaccination), Argentina)34
67 (58–78) and 88 (75–102) (naïve population, India)
8.04 (6.96–9.36) and 10.56 (9–12.24) (Rt vaccinated 
population, India)35
Herd size (N) 70 27
Transmission parameter (β) Calculated for each scenario Next-Generation matrix approach
64
Mean duration of latent period ( )1λ 4.6 days 36 3.1–4.8 days latent period37
Mean duration of infectious period 
σ( )I1 1.7 days 36
Probability of becoming a carrier (θ) 0 0.5 38,39
Ratio transmission from carrier: 
transmission from infectious individuals (ω) 0 0.000 to 0.024
1
500
 estimated by Tenzin et al.18
Mean duration of the carrier state ( )C1σ 182.625 days 61,62
Mean in-herd residency 
μ( )1 3652.5 days 365.25 days to 7305 days
11.08 years65
Fulani tend to keep their cattle until they are 8 years old 
(or longer if they are reproductively proficient)51
Table 2. Model parameters and the values used in the model.
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shows that high herd immunity (small Rt) results in smaller outbreaks on average. We have utilised Rt to define 
the period of reduced risk following an outbreak.
Data availability
The code used to generate and analyse the data during the current study will be made available to readers upon 
publication.
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